Manhattan Scientifics Inc (MHTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MHTX Annual Balance Sheets →
Tracking balance sheet results across Manhattan Scientifics Inc to Jun 30 2023 helps illustrate how Jun 30 2024's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Other Current Assets0.04
Prepaid Expense, Current AS0.01
Total Current Assets0.05
Long-term investments0.03
Other Assets, Noncurrent0.03
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.04
Total Assets0.07
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.16
Accrued Liabilities, Current AC2.18
Notes Payable, Current NO0.06
Deferred Revenue, Current DE0.02
Total Current Liabilities2.42
Total Long-term Debt0.00
Total Liabilities2.42
Stockholders' Equity
Common Stock Value1.06
Additional Paid In Capital Common Stock69.00
Retained Earnings / Accumulated Deficit-72.96
Other Equity-0.50
Common Stockholder's Equity-3.40
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-3.40
Liabilities & Stockholder's Equity0.07
4 historic quarters locked

Sign in to unlock the full Manhattan Scientifics Inc balance sheet history.

About Manhattan Scientifics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240630)
  • Filed with the SEC: August 19, 2024
  • Source: mhtx_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-24-005089

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.